Artificial intelligence is becoming the primary interface through which pharmaceutical information is accessed and interpreted. However, most pharma content ecosystems remain optimized for search engines and human readers — not for AI systems that now determine which treatments are surfaced, described, and remembered. This misalignment is already creating measurable consequences. While user behavior remains brand-led, AI-generated responses are predominantly INN-led. As a result, brands are increasingly absent from high-intent informational moments. If a brand is…

Inspired by insights from CPHI Frankfurt 2025 The global pharmaceutical industry continues to evolve at extraordinary speed, driven by scientific discovery, digital transformation, and shifting market expectations. This year’s CPHI Frankfurt 2025 showcased that evolution on an unprecedented scale, bringing together 67,000 visitors, 2,400 exhibitors, and 260 speakers from across the world. One message cut through the noise:Innovation is only valuable when it is connected — to strategy, to communication, and to people. 1. A…